MedTrace Logo

Philips Non-Invasive Blood Pressure Validation Study

NCT06682312 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2024-11-12

No results posted yet for this study

Summary

The purpose of this study is to provide supporting documentation of the blood pressure performance for the Philips EarlyVue VS30 monitor on the intended adult and pediatric population. The same arm sequential method with dual observer auscultation will be used to collect data.

Conditions

  • Non Invasive Blood Pressure

Interventions

DEVICE

Non-invasive blood pressure

Manual blood pressure via sphygmomanometer Or Non invasive blood pressure via earlyvue VS30 Monitor

Sponsors & Collaborators

  • Element Materials Technology

    collaborator INDUSTRY

  • Philips Clinical & Medical Affairs Global

    lead INDUSTRY

Eligibility

Min Age
3 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-14
Primary Completion
2024-10-23
Completion
2024-10-23
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06682312 on ClinicalTrials.gov